@BakhshiHooman@rblument1@MichaelJBlaha@khurramn1 The tricky part of this decision making for me is when a asymptomatic patient says they have a friend who was found to have elevated calcium score and then multi vessel CAD thus saving his/her life. How would you handle that conversation @drjohnm@venkmurthy@rblument1
The latest work from Cedars-Sinai Medical Center by first author Dr. Rahul Gupta and his team is now featured in RCM!
Welcome to read this article 👉: https://t.co/Gf6fysm9yh
Article Highlights:
💡 Are drug-coated #balloons ready to move beyond in-stent #restenosis?
This review examines the expanding clinical evidence supporting #DCB use in de novo #lesions, #bifurcation disease, high-bleeding-risk patients, and #acutecoronarysyndromes, while discussing their evolving role as a potential #stent-free strategy in contemporary #PCI.
✒️ Authors: Rahul Gupta, Chandrashekar bohra @Shekarbohra , Krishna Santosh Vemuri, Gaurav Arora, Amit Gulati, Isha Ranadive @INRanadive , Samin K. Sharma, Amit Hooda @AmithoodaMD (Corresponding author)
🏪 Affiliations: Cedars-Sinai Center; Cardiovascular Institute of Central Florida/HCA Ocala Hospital; Mount Sinai Fuster Heart Hospital @MountSinaiHeart ; Mount Sinai Beth Israel
📖 Don’t miss this citable reference for your future research!
Citation format:
Gupta R, Bohra C, Vemuri KS, et al. Drug-Coated Balloons Beyond In-Stent Restenosis. Rev. Cardiovasc. Med. 2026, 27(2), 45108.
Welcome to submit your work via our submission link 👉: https://t.co/0im2Ul0zPy
#RCM welcomes review papers, research articles and other types of research in both #cardiovascular medicine and cardiovascular disease.
📖 Click here for author guidelines:
https://t.co/tKLwCKyDww
#InterventionalCardiology #DrugCoatedBalloon #DrugElutingBalloon #DrugElutingStent #InStentRestenosis #antiplatelet #CoronaryArteryDisease #RCMPaper
⭐️Sharing a new #Rview titled "Drug-Coated Balloons Beyond In-Stent Restenosis"
🔗Read more at: https://t.co/08CRKh0Hnl
This review contributed by @AmithoodaMD et al. explores the evolving role, evidence base, and expanding indications of #DCB-related therapy beyond #ISR.
Insights on baseline PV flow patterns from COAPT trial #TEER
PV systolic flow reversal (PVSFR) identifies pts w/ more advanced heart disease
Consistent reduction in 2-year events irrespective of PVSFR
https://t.co/eJHPSp7sEY…
Thank you for this opportunity
@GreggWStone
We are very excited to announce the launch of our new app called IVUSAID from Mount Sinai Heart!
IVUSAID is our 12th app and can be downloaded for free on your phones as well as accessible through https://t.co/YtBOVSR6xR
#CardioTwitter